Drug Safety 2018
Date: | 11-Jun-18 to 12-Jun-18 |
Location: | Holiday Inn / United Kingdom |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
For drugs anywhere, it's the safety in patients which is a huge issue, constantly under surveillance, irrespective of where the drug is in its pipeline.
The Global Pharmaceutical Market currently has a market value of $1057 billion. If a drug is found to be unsafe, causing serious side effects, it can have a huge knock on effect on revenue, causing huge losses to pharmaceutical companies manufacturing the drug.
Drug Safety 2018 aims to discuss the latest findings and current thinking on pharmacovigilance. Importantly, it will address the newest regulatory updates and interpretations of them, including the impact of the vital and much awaited Clinical Trial Regulations.
Network and learn from:
- David Lewis, Senior Adviser Pharmacovigilance, CMO Patient Safety, Novartis
- Peter De Veene, Senior Vice President and Head Global Drug Safety and QPPV, Grünenthal
- Simon Ashworth, VP EU QPPV, EU Head Compliance and Marketed Products and Head PV Affiliate Relations, Takeda
- Kirsty Wydenbach, Deputy Unit Manager, Clinical Trials Unit, MHRA
- John Solomon, Head of Pharmacovigilance-UK & Ireland, Sanofi
- Bjarke Naver, Head of Pharmacovigilance Science, LEO Pharma
- Sue Rees, EU QPPV, Executive Director, Global Safety, Amgen
- Jackie Roberts, Executive Director Regulatory, Pharmacovigilance and Medical UK/IE/Malta and MENA, Accord Healthcare
- Philip Eichorn, Senior Director, Worldwide Safety and Regulatory, Pfizer
- Kashif Sheikh, Safety Surveillance Specialist, Novo Nordisk
FEATURED HIGHLIGHTS:
- MHRA spotlight presentation on the future of Clinical Trial Regulations
- Hear first experiences with the new Eudravigilence system
- Gain insight into how competitors are reporting adverse effects under the new legislation and system
- Discuss risk-minimisation and signal detection strategies with industry-thought leaders
- Evaluate the benefits and pitfalls of patient involvement and patient support programs
The Global Pharmaceutical Market currently has a market value of $1057 billion. If a drug is found to be unsafe, causing serious side effects, it can have a huge knock on effect on revenue, causing huge losses to pharmaceutical companies manufacturing the drug.
Drug Safety 2018 aims to discuss the latest findings and current thinking on pharmacovigilance. Importantly, it will address the newest regulatory updates and interpretations of them, including the impact of the vital and much awaited Clinical Trial Regulations.
Network and learn from:
- David Lewis, Senior Adviser Pharmacovigilance, CMO Patient Safety, Novartis
- Peter De Veene, Senior Vice President and Head Global Drug Safety and QPPV, Grünenthal
- Simon Ashworth, VP EU QPPV, EU Head Compliance and Marketed Products and Head PV Affiliate Relations, Takeda
- Kirsty Wydenbach, Deputy Unit Manager, Clinical Trials Unit, MHRA
- John Solomon, Head of Pharmacovigilance-UK & Ireland, Sanofi
- Bjarke Naver, Head of Pharmacovigilance Science, LEO Pharma
- Sue Rees, EU QPPV, Executive Director, Global Safety, Amgen
- Jackie Roberts, Executive Director Regulatory, Pharmacovigilance and Medical UK/IE/Malta and MENA, Accord Healthcare
- Philip Eichorn, Senior Director, Worldwide Safety and Regulatory, Pfizer
- Kashif Sheikh, Safety Surveillance Specialist, Novo Nordisk
FEATURED HIGHLIGHTS:
- MHRA spotlight presentation on the future of Clinical Trial Regulations
- Hear first experiences with the new Eudravigilence system
- Gain insight into how competitors are reporting adverse effects under the new legislation and system
- Discuss risk-minimisation and signal detection strategies with industry-thought leaders
- Evaluate the benefits and pitfalls of patient involvement and patient support programs
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today